Federal Register / Vol. 84, No. 214 / Tuesday, November 5, 2019 / Notices 59645

Authority: 42 U.S.C. 6213; and 30 CFR company plans to bulk manufacture Controlled substance Drug Schedule 556.511–556.515. these drugs as synthetics. No other code Walter D. Cruickshank, activities for these drug codes are Hydromorphone ...... 9150 II Acting Director, Bureau of Ocean Energy authorized for this registration. Hydrocodone ...... 9193 II Management. Morphine ...... 9300 II Dated: October 18, 2019. Oripavine ...... 9330 II [FR Doc. 2019–24052 Filed 11–4–19; 8:45 am] William T. McDermott, Thebaine ...... 9333 II BILLING CODE 4310–MR–P Assistant Administrator. Opium extracts ...... 9610 II Opium fluid extract ...... 9620 II [FR Doc. 2019–24107 Filed 11–4–19; 8:45 am] Opium tincture ...... 9630 II BILLING CODE 4410–09–P Opium, powdered ...... 9639 II DEPARTMENT OF JUSTICE Opium, granulated ...... 9640 II Oxymorphone ...... 9652 II Drug Enforcement Administration Noroxymorphone ...... 9668 II DEPARTMENT OF JUSTICE Tapentadol ...... 9780 II [Docket No. DEA–536] Drug Enforcement Administration The company plans to manufacture Bulk Manufacturer of Controlled [Docket No. DEA–526] the listed controlled substances as an Substances Application: Organix, Inc. Active Pharmaceutical Ingredient (API) Bulk Manufacturer of Controlled for supply to its customers. In reference ACTION: Notice of application. Substances Application: Noramco Inc. to drug codes 7360 (marihuana) and DATES: Registered bulk manufacturers of 7370 (tetrahydrocannabinols), the ACTION: Notice of application. the affected basic classes, and company plans to bulk manufacture these drugs as synthetics. No other applicants therefore, may file written DATES: Registered bulk manufacturer of comments on or objections to the activities for these drug codes are the affected basic classes, and authorized for this registration. issuance of the proposed registration on applicants therefore, may file written or before January 6, 2020. comments on or objections to the Dated: October 22, 2019. ADDRESSES: Written comments should issuance of the proposed registration on William T. McDermott, be sent to: Drug Enforcement or before January 6, 2020. Assistant Administrator. Administration, Attention: DEA Federal ADDRESSES: Written comments should [FR Doc. 2019–24106 Filed 11–4–19; 8:45 am] Register Representative/DPW, 8701 be sent to: Drug Enforcement BILLING CODE 4410–09–P Morrissette Drive, Springfield, Virginia Administration, Attention: DEA Federal 22152. Register Representative/DPW, 8701 SUPPLEMENTARY INFORMATION: In Morrissette Drive, Springfield, Virginia DEPARTMENT OF JUSTICE accordance with 21 CFR 1301.33(a), this 22152. is notice that on September 9, 2019, Drug Enforcement Administration SUPPLEMENTARY INFORMATION: In Organix, Inc., 240 Salem Street, accordance with 21 CFR 1301.33(a), this Woburn, Massachusetts 01801–2029 [Docket No. DEA–530] is notice that on August 6, 2019, applied to be registered as a bulk Noramco Inc., 500 Swedes Landing Importer of Controlled Substances manufacturer of the following basic Road, Wilmington, Delaware 19801– Registration classes of controlled substances: 4417 applied to be registered as a bulk manufacturer of the following basic ACTION: Notice of registration. Controlled substance Drug Schedule code classes of controlled substances: SUMMARY: The registrants listed below Gamma Hydroxybutyric Acid ... 2010 I have applied for and been granted Controlled substance Drug Schedule Lysergic acid diethylamide ...... 7315 I code registration by the Drug Enforcement Marihuana ...... 7360 I Tetrahydrocannabinols ...... 7370 I Marihuana ...... 7360 I Administration (DEA) as importers of Dimethyltryptamine ...... 7435 I Tetrahydrocannabinols ...... 7370 I schedule I and II controlled substances. Psilocybin ...... 7437 I Codeine-N-oxide ...... 9053 I The companies listed below applied Psilocyn ...... 7438 I Dihydromorphine ...... 9145 I to be registered as an importers of Heroin ...... 9200 I Hydromorphinol ...... 9301 I Morphine ...... 9300 II Morphine-N-oxide ...... 9307 I various basic classes of schedule I and Amphetamine ...... 1100 II II controlled substances. Information on The company plans to synthesize the Methylphenidate ...... 1724 II previously published notices is listed in listed controlled substances for Nabilone ...... 7379 II the table below. No comments or Phenylacetone ...... 8501 II distribution to its customers. In Codeine ...... 9050 II objections were submitted and no reference to drug codes 7360 Dihydrocodeine ...... 9120 II requests for a hearing were submitted (marihuana) and 7370 (THC), the Oxycodone ...... 9143 II for these notices.

Companies FR docket Published

Catalent Pharma Solutions, LLC ...... 84 FR 36945 July 30, 2019. Research Triangle Institute ...... 84 FR 36941 July 30, 2019.

The DEA has considered the factors in schedule I and II controlled substances May 1, 1971. The DEA investigated each 21 U.S.C. 823, 952(a) and 958(a) and is consistent with the public interest of the company’s maintenance of determined that the registration of the and with United States obligations effective controls against diversion by listed registrants to import the under international treaties, inspecting and testing each company’s applicable various basic classes of conventions, or protocols in effect on physical security systems, verifying

VerDate Sep<11>2014 16:34 Nov 04, 2019 Jkt 250001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\05NON1.SGM 05NON1 khammond on DSKJM1Z7X2PROD with NOTICES